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Abstract 
Eight  compounds, cyclo-(Pro-Tryp) (1), N-[2-(1H-indol-3-yl)-2-oxo-ethyl] acetamide (2), cyclo-(Pro-Tyr) (3), 
cyclo-(Pro-Phe) (4), cyclo-trans-4-OH-(Pro-Phe) (5), cyclo-(Pro-Leu) (6), cyclo-(Pro-Val) (7), and  uracil (8) were 
isolated from the culture broth of the marine Micromonospora ectrinospora G017 strain. The structures of the isolated 
compounds were established on the basis of their spectral data, including mass spectrometry and NMR. 
Keywords. Micromonospora ectrinospora G017 strain, cyclo-(Pro-Tryp), N-[2-(1H-Indol-3-yl)-2-oxo-ethyl] 
acetamide, cyclo-(Pro-Tyr), cyclo-(Pro-Phe), cyclo-trans-4-OH-(Pro-Phe), cyclo-(Pro-Leu), cyclo-(Pro-Val), uracil. 
 
 
1. INTRODUCTION 
 
Marine bacteria are considered to play a central 
role as symbionts of most marine invertebrates and 
also represent one of the most novel biomedicial 
resources remaining to be explored [1].  
In search of bioactive metabolite from marine 
bacteria, we examined the extract of the culture 
broth of the marine Micromonospora ectrinospora 
G017 strain. During our screening program, the 
EtOAc extract of this strain exhibited an inhibition 
against  Mycobacterium tuberculosis. Herein, we 
described the isolation and structural determination 
of eight compounds (1-8) from the EtOAc extract of 
the culture broth of M. ectrinospora G017. 
 
2. EXPERIMENTAL 
 
2.1. General Experiment procedures 
 
1
H, 
13
C-NMR and 2D NMR spectra were 
recorded on a Brucker 400 and 600 MHz 
spectrometer with TMS as internal standard. High 
resolution ESI mass spectra were measured an a FT-
ICR MS VARIAN 910 spectrometer. Thin-layer 
chromatography (TLC) used TLC silica gel Merck 
60 F254. Column chromatography (CC) were carried 
out on silica gel 40-63 µm. For preparative HPLC 
purifications using a C18 (21.2x150 mm) column, for 
analytic HPLC using a C6 phenyl 4.6 column. 
 
2.2. Bacteria isolation and fermentation 
 
The marine sediment was collected in Ha Long 
Bay – Quang Ninh on July 2012. The sediment 
sample (1 g) was added to the 10 mL of sterile sea 
water in a conical flask. The flask was agitated for 
about one hour. The marine sediment was filtered and 
the filtrate was serially diluted to obtain 10
-1
 to 10
-7
 
dilutions using the sterilized sea water. An aliquot of 
100 μL of each dilution was spread on the media. 
Different media like Starch Casein Agar (SCA), 
Glycerol Asparagine Agar (GA Agar), Humic acid-B 
vitamin agar (HV Agar) and Glucose yeast malt 
extract agar (GYM) were used for isolation of 
actinomycetes. The media containing 50 % of sterile 
sea water were supplemented with rifampicin (5 
μg/mL) and nystatin (25 μg/mL) (Himedia Mumbai) 
to inhibit bacterial and fungal contamination, 
respectively. The petriplates were incubated up to 3 
weeks at 28 °C. The isolated discrete colonies were 
observed and used for identification. The 
fermentation was carried out in 3 L flask using a 
modification of the published method [2]. 
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2.3. Extraction and Isolation 
 
Culture broth (10 L) of M. ectrinospora G017 
strain was filtered to remove the bacteria, and then 
extracted with ethyl acetate (7 L × 5 times). The 
extract solution was concentrated under diminished 
pressure to give 1.7 g. This residue was applied to a 
silica gel column chromatography (CC), eluted with 
CH2Cl2/MeOH mixture (from 0 to 100 % of MeOH 
in CH2Cl2) to give 16 fractions. Fraction 8 (82 mg) 
was purified by preparative HPLC using 
acetonitrile/water mixture (10-30 % ACN, 5 % 
formic acid in ACN) to yield 1.0 mg of 1 (tR 32 
min), 3.3 mg of 4 (tR 24.4 min), 4.5 mg of 6 (tR 22.3 
min) and 10 mg of 7 (tR 13.7 min). Fraction 13 (59 
mg) was separated by preparative HPLC using 
acetonitrile/water mixture (5-40 % ACN, 5 % formic 
acid in ACN) to obtained 1.5 mg of 2 (tR 24.5 min), 
11 mg of 3 (tR 17.6 min) and 4.5 mg of 5 (tR 20.5 
min). Fraction 15 (34 mg) was purified by 
preparative TLC (CH2Cl2/MeOH: 9.5/0.5) to afford 
8 (6 mg). 
Cyclo-(Pro-Tryp) (1): White solid; HRESI-
MS: m/z 284.1409 [M+H]
+
 (Calcd. 284.1399 for 
C16H18N3O2); 
1
H-NMR (600 MHz, CD3OD): δH 
(ppm) 0.95 (1H, m, Ha-5), 1.49 (1H, m, Ha-4), 1.71 
(1H, m, Hb-4), 1.97 (1H, m, Hb-5); 3.29 (1H, m, Ha-
3), 3.50 (1H, m, Hb-3), 3.45 (2H, m, H-10), 4.01 
(1H, m, H-6), 4.42 (1H, m, H-9), 7.10 (1H, s, H-2’), 
7.02-7.58 (4H, H-aromatic); 
13
C-NMR (150 MHz, 
CD3OD): δC (ppm) 22.5 (C-4), 29.1 (C-10), 29.2 (C-
5), 45.9 (C-3), 57.2 (C-9), 60.7 (C-6), 109.5-138.0 
(C-aromatic), 125.6 (C-2’), 167.4 (C=O); 170.3 
(C=O). 
N-[2-(1H-Indol-3-yl)-2-oxo-ethyl] acetamide 
(2): White solid; HRESI-MS: m/z 217.0976 [M+H]
+
 
(Calcd. 217.0977 for C12H13N2O2); 
1
H-NMR (600 
MHz, CD3OD): δH (ppm) 2.08 (3H, s, COCH3), 4.60 
(2H, s, -CH2-), 7.25-8.22 (4H, m, H-aromatic), 8.24 
(1H, s, H-2); 
13
C-NMR (150 MHz, CD3OD): δC 
(ppm) 22.5 (COCH3), 44.8 (-COCH2N-), 112.9-
138.3 (C-aromatic, C-2), 173.7 (C=O), 191.9 (C=O). 
Cyclo-(Pro-Tyr) (3): White solid; HRESI-MS: 
m/z 261.1224 [M+H]
+
 (Calcd. 261.1239 for 
C16H17N2O3); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 1.25 (1H, m, Ha-4), 1.81 (2H, m, Hb-4, Ha-5), 
2.13 (1H, m, Hb-5), 3.07 (2H, m, H-10), 3.40 (1H, 
m, Ha-3), 3.57 (1H, m, Hb-3), 4.06 (1H, m, H-6), 
4.38 (1H, m, H-9), 6.73 (2H, d, J = 8.5 Hz, H-2’, 6’), 
7.05 (2H, d, J = 8.5 Hz, H-3’, 5’); 13C-NMR (100 
MHz, CD3OD): δC (ppm) 21.3 (C-4), 28.0 (C-5), 
36.3 (C-10), 44.5 (C-3), 56.5 (C-9), 58.7 (C-6), 
126.4 (C-1’), 130.7 (C-2’, 6’), 114.8 (C-3’, 5’), 
156.3 (C-4’), 165.6 (C=O), 169.4 (C=O). 
Cyclo-(Pro-Phe) (4): White solid; HRESI-MS: 
m/z 245.1316 [M+H]
+
 (Calcd. 245.1290 for 
C14H17N2O2); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 1.60 (2H, m, Ha-4, Ha-5), 1.91-2.07 (3H, m, 
Hb-4, Hb- 5, Ha-10), 2.64 (1H, m, Hb-10), 3.02 (1H, 
dd, J = 4.8, 13.6 Hz, Ha-3), 3.22 (1H, dd, J = 4.4, 
13.6 Hz, Hb-3), 3.59 (1H, m, H-6), 4.22 (1H, t, J = 
4.8 Hz, H-9), 7.20-7.33 (5H, aromatic); 
13
C-NMR 
(100 MHz, CD3OD): δC (ppm) 21.1 (C-4), 28.4 (C-
5), 39.6 (C-10), 44.7 (C-3),  57.7 (C-9), 58.4 (C-6), 
127.1-129.9 (CH- aromatic), 135.3 (C-1’), 166.0 
(C=O), 170.0 (C=O). 
Cyclo-trans-4-OH-(Pro-Phe) (5): White solid; 
HRESI-MS: m/z 261.1231 [M+H]
+
 (Calcd. 261.1239 
for C14H17N2O3); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 1.40 (1H, ddd, J = 4.8, 12.0, 12.8 Hz, Ha-5), 
2.10 (1H, dd, J = 4.8, 13.2 Hz, Hb-5), 3.20 (2H, m, 
H-10), 3.35 (1H, m, Ha-3), 3.74 (1H, dd, J = 4.8, 
12.8 Hz, Hb-3), 4.30 (1H, t, J = 4.8 Hz, H-4), 4.39 
(1H, m, H-6), 4.50 (1H, m, H-9), 7.28 (5H, H-
aromatic); 
13
C-NMR (100 MHz, CD3OD): δC (ppm) 
36.6 (C-10), 37.5 (C-5), 53.8 (C-3), 56.2 (C-9), 56.9 
(C-6), 67.1 (C-4), 126.7 (C-4’), 128.1 (C-3’, 5’), 
129.6 (C-2’, 6’), 136.0 (C-1’), 165.7 (C=O), 169.9 
(C=O). 
Cyclo-(Pro-Leu) (6): White solid; HRESI-MS: 
m/z 211.1432 [M+H]
+
 (Calcd. 211.1447 for 
C11H19N2O2); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 0.97 (3H, d, J = 6.4 Hz, CH3-12), 0.98 (3H, d, 
J = 6.4 Hz, CH3-13), 1.55 (1H, m, H-11), 1.90-2.05 
(5H, m, CH2-4, 5, H-10), 2.31 (1H, m, H-10), 3.52 
(2H, m, H-3), 4.15 (1H, m, H-6), 4.30 (1H, m, H-9); 
13
C-NMR (100 MHz, CD3OD): δC (ppm) 20.8 (C-
12), 21.9 (C-13), 22.2 (C-5), 24.3 (C-11), 27.7 (C-4), 
38.0 (C-10), 45.0 (C-3), 53.2 (C-9), 58,9 (C-6), 
167.5 (C=O), 171.4 (C=O). 
Cyclo-(Pro-Val) (7): White solid; HRESI-MS: 
m/z 197.1262 [M+H]
+
 (Calcd. 197.1290 for 
C10H17N2O2); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 0.95 (3H, d, J = 6.8 Hz, CH3-11), 1.11 (3H, d, 
J = 6.8 Hz, CH3-12), 1.94-2.05 (3H, m, CH2-4, Ha-
5), 2.33 (1H, m, Hb-5), 2.50 (1H, m, H-10), 3.54 
(2H, m, H-3), 4.05 (1H, m, H-6), 4.22 (1H, m, H-9); 
13
C-NMR (100 MHz, CD3OD): δC (ppm) 15.2 (C-
11), 17.4 (C-12), 21.8 (C-4), 28.1 (C-5), 28.5 (C-10), 
44.8 (C-3), 58.6 (C-9), 60.1 (C-6), 166.2 (C=O), 
171.2 (C=O). 
Uracil (8): White solid; HRESI-MS: m/z 
135.0170 [M+Na]
+
 (Calcd. 135.0170 for 
C4H4N2NaO2); 
1
H-NMR (400 MHz, CD3OD): δH 
(ppm) 5.61 (1H, d, J = 7.6 Hz, H-5), 7.39 (1H, d, J = 
7.6 Hz, H-6); 
13
C-NMR (100 MHz, CD3OD): δC 
(ppm) 100.3 (C-5), 142.1 (C-6), 152.1 (C-1), 165.9 
(C-4). 
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3. RESULTS AND DISCUSSION 
 
Compound 1 was isolated as a white solid. In its 
positive HRESI mass spectrum, the pseudo-
molecular ion was observed at m/z 284.1409 
[M+H]
+
, suggesting a molecular formula of 
C16H19N3O2. The 
1
H-NMR spectrum of 1 indicated 
the presence of five aromatic protons at δH 7.01-7.58 
and ten protons in the aliphatic region. Analyses of 
the 
13
C-NMR and DEPT spectra with the aid of the 
HSQC of 1 indicated the presence of 16 carbons, 
including four sp
3
 methylenes, two sp
3
 methines, 
eight aromatic carbons (five methines and three 
quaternary carbons) and two carbonyl carbons at δC 
167.4 and 170.3. Analysis of COSY spectrum 
revealed the presence of three spin – spin coupling 
systems: CH2-3/CH2-4/CH2-5/CH-6; CH-9/CH2-10 
and H-4’/H-5’/H-6’/H-7’. Detailed analysis of 2D 
NMR spectra, especially HMBC spectrum allowed 
determining the structure of 1 as cyclo-(Pro-Tryp). 
This cyclodipeptide was previously described [3, 4]. 
Compound 2 was obtained as a white amorphous 
solid. The HRESI mass spectrum of 2 presented a 
base peak at m/z 217.0976 [M+H]
+
, consistent with 
the molecular formula C12H12N2O2. In the 
1
H-NMR 
spectrum, the signals of five protons at the aromatic 
region of 2 was close to those of 1. However, at the 
aliphatic region in the 
1
H NMR of 2, only signals of 
an acetyl at δH 2.08 and a methylene at δH 4.60 were 
observed. The 
13
C-NMR and DEPT spectra of 2 
showed signals of the groups observed above with 
additional signals of a ketone (δC 191.9), a carboxyl 
group (δC 173.7) and three quaternary aromatic 
carbons. The chemical shifts of the methylene (δC 
44.8, δH 4.60) suggested its connection to nitrogen. 
Analysis of the HMBC spectrum revealed the 
presence of indole moiety as in the structure of 1. 
Finally, the structure of 2 was established by cross-
peaks of the methylene protons at δH 4.60 to the 
carbons at δC 191.9 (ketone), 173.7 (acetyl) and C-3 
of the indole ring (δC 115.8). Comparison of the 
NMR data with those reported in the literature 
determined the structure of 2 as N-[2-(1H-indol-3-
yl)-2-oxo-ethyl] acetamide [5-7]. 
Compound 3 was isolated as a white solid. In its 
positive HRESI mass spectrum, the pseudo-
molecular ion was observed at m/z 261.1224 
[M+H]
+
, suggesting a molecular formula 
C14H16N2O3. In the 
1
H-NMR spectrum, the signals at 
the aliphatic region of 3 was close to those of 1. The 
differences between 3 and 1 were signals at aromatic 
region: the signals of the five aromatic protons in 1 
were replaced by those of an A2B2 system [δH 6.73 
(2H, d, J = 8.5 Hz, H-2’, 6’), 7.05 (2H, d, J = 8.5 
Hz, H-3’, 5’)] in 3. Detailed analysis of the 13C-
NMR and DEPT spectra with the aid of the 2D 
NMR spectra indicated the structure of 3 which was 
a cyclodipeptide, forming from a proline and a         
4-hydroxy-phenylalanine units. The NMR data of 3 
were in agreement with those reported in the 
literature for cyclo-(Pro-Tyr) [8].  
 
  
Figure 1: Secondary metabolites from the marine 
bacterium M. ectrinospora G017 
 
Compound 4 was isolated as a white solid. In its 
positive HRESI mass spectrum, the pseudo-
molecular ion was observed at m/z 245.1316 
[M+H]
+
, consistent with the molecular formula 
C14H16N2O2. The 1D-NMR spectra (
1
H and 
13
C) of 
compound 4 were close to those of 3, except for the 
presence of a phenyl ring instead of the A2B2 
system. This data strongly suggested that the 4-
hydroxy-phenylalanine fragment in 3 was replaced 
by a phenylalanine moiety in 4. Comparison of 
NMR data revealed the structure of 4 which was 
identical to cyclo-(Pro-Phe) [9].    
1D-NMR spectra of compound 5 were similar to 
those of 4, except for the presence of an oxymethine 
group at δH 4.30 (1H, t, J = 4.8 Hz, H-4) and δC 67.1 
(C-4) instead of a methylene group of 4. This 
observation suggested that 5 should be a 
hydroxylated derivative of 4. Analyses of the 2D-
NMR spectra indicated 5 being  cyclo-trans-4-OH-
(Pro-Phe) [10]. 
Compound 6 was isolated as a white amorphous 
solid. The HRESI mass spectrum of 6 presented a 
base peak at m/z 211.1432 [M+H]
+
 suggesting a 
molecular formula C11H18N2O2. Considering the 
molecular formula and the NMR data, the structure 
of compound 6 could be a cyclodipeptide. Analyses 
of the 2D-NMR spectra demonstrated the presence 
of two amino acid moieties: proline and leucine. 
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Thus, compound 5 was established to be cyclo-(Pro-
Leu) [10, 11]. 
HRESI mass spectrum of 7 presented a base peak 
at m/z 197.1262 [M+H]
+
 suggesting a molecular 
formula C10H16N2O2. The 1D NMR (
1
H, 
13
C NMR) 
spectra of compound 7 revealed structural similarity 
to 6, except for the absence of a methylene group in 
the molecule of 7. Complete analysis of the NMR 
spectra and comparison with reported NMR data 
indicated that compound 7 was cyclo-(Pro-Val)    
[10, 11]. 
Compound 8 was obtained as a white amorphous 
solid and determined to be uracil. Its NMR data were 
consistent with those reported in the literature [11]. 
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